118 related articles for article (PubMed ID: 32010925)
1. The Patient in Your Alzheimer's Disease Study May be in Another: Duplication and Deception in Clinical Trials of Alzheimer's Disease.
Shiovitz T; Steinmiller B; Steinmetz C; Perez S; Oseas R
J Prev Alzheimers Dis; 2020; 7(1):43-46. PubMed ID: 32010925
[TBL] [Abstract][Full Text] [Related]
2. Frequency of concealment, fabrication and falsification of study data by deceptive subjects.
Devine EG; Pingitore AM; Margiotta KN; Hadaway NA; Reid K; Peebles K; Hyun JW
Contemp Clin Trials Commun; 2021 Mar; 21():100713. PubMed ID: 33604482
[TBL] [Abstract][Full Text] [Related]
3. Concealment and fabrication by experienced research subjects.
Devine EG; Waters ME; Putnam M; Surprise C; O'Malley K; Richambault C; Fishman RL; Knapp CM; Patterson EH; Sarid-Segal O; Streeter C; Colanari L; Ciraulo DA
Clin Trials; 2013; 10(6):935-48. PubMed ID: 23867223
[TBL] [Abstract][Full Text] [Related]
4. Study partners: essential collaborators in discovering treatments for Alzheimer's disease.
Largent EA; Karlawish J; Grill JD
Alzheimers Res Ther; 2018 Sep; 10(1):101. PubMed ID: 30261910
[TBL] [Abstract][Full Text] [Related]
5. Galantamine for Alzheimer's disease.
Olin J; Schneider L
Cochrane Database Syst Rev; 2001; (4):CD001747. PubMed ID: 11687119
[TBL] [Abstract][Full Text] [Related]
6. Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials.
Langbaum JB; Zissimopoulos J; Au R; Bose N; Edgar CJ; Ehrenberg E; Fillit H; Hill CV; Hughes L; Irizarry M; Kremen S; Lakdawalla D; Lynn N; Malzbender K; Maruyama T; Massett HA; Patel D; Peneva D; Reiman EM; Romero K; Routledge C; Weiner MW; Weninger S; Aisen PS
Alzheimers Dement; 2023 Feb; 19(2):696-707. PubMed ID: 35946590
[TBL] [Abstract][Full Text] [Related]
7. Neuropsychological, Psychiatric, and Functional Correlates of Clinical Trial Enrollment.
Hammers DB; Foster NL; Hoffman JM; Greene TH; Duff K
J Prev Alzheimers Dis; 2019; 6(4):242-247. PubMed ID: 31686096
[TBL] [Abstract][Full Text] [Related]
8. Machine Learning Algorithm Helps Identify Non-Diagnosed Prodromal Alzheimer's Disease Patients in the General Population.
Uspenskaya-Cadoz O; Alamuri C; Wang L; Yang M; Khinda S; Nigmatullina Y; Cao T; Kayal N; O'Keefe M; Rubel C
J Prev Alzheimers Dis; 2019; 6(3):185-191. PubMed ID: 31062833
[TBL] [Abstract][Full Text] [Related]
9. Constructing a Local Potential Participant Registry to Improve Alzheimer's Disease Clinical Research Recruitment.
Grill JD; Hoang D; Gillen DL; Cox CG; Gombosev A; Klein K; O'Leary S; Witbracht M; Pierce A
J Alzheimers Dis; 2018; 63(3):1055-1063. PubMed ID: 29710723
[TBL] [Abstract][Full Text] [Related]
10. Selegiline for Alzheimer's disease.
Birks J; Flicker L
Cochrane Database Syst Rev; 2003; (1):CD000442. PubMed ID: 12535396
[TBL] [Abstract][Full Text] [Related]
11. Nimodipine for primary degenerative, mixed and vascular dementia.
López-Arrieta JM; Birks J
Cochrane Database Syst Rev; 2002; (3):CD000147. PubMed ID: 12137606
[TBL] [Abstract][Full Text] [Related]
12. Implementing a Memory Clinic Model to Facilitate Recruitment into Early Phase Clinical Trials for Mild Cognitive Impairment and Alzheimer's Disease.
Park L; Kouhanim C; Lee S; Mendoza Z; Patrick K; Gertsik L; Aguilar C; Gullaba D; Semenova S; Jhee S
J Prev Alzheimers Dis; 2019; 6(2):135-138. PubMed ID: 30756120
[TBL] [Abstract][Full Text] [Related]
13. Motivators for Alzheimer's disease clinical trial participation.
Bardach SH; Holmes SD; Jicha GA
Aging Clin Exp Res; 2018 Feb; 30(2):209-212. PubMed ID: 28523610
[TBL] [Abstract][Full Text] [Related]
14. Rivastigmine for Alzheimer's disease.
Birks JS; Grimley Evans J
Cochrane Database Syst Rev; 2015 Apr; (4):CD001191. PubMed ID: 25858345
[TBL] [Abstract][Full Text] [Related]
15. European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials.
Vermunt L; Veal CD; Ter Meulen L; Chrysostomou C; van der Flier W; Frisoni GB; Guessous I; Kivipelto M; Marizzoni M; Martinez-Lage P; Molinuevo JL; Porteous D; Ritchie K; Scheltens P; Ousset PJ; Ritchie CW; Luscan G; Brookes AJ; Visser PJ
Alzheimers Dement; 2018 Jun; 14(6):837-842. PubMed ID: 29604264
[TBL] [Abstract][Full Text] [Related]
16. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
Farina N; Llewellyn D; Isaac MG; Tabet N
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002854. PubMed ID: 28128435
[TBL] [Abstract][Full Text] [Related]
17. Nimodipine for primary degenerative, mixed and vascular dementia.
López-Arrieta ; Birks J
Cochrane Database Syst Rev; 2001; (1):CD000147. PubMed ID: 11279679
[TBL] [Abstract][Full Text] [Related]
18. Task force on Alzheimer's disease trial methodology: recruitment and retention, data management and analysis. The use of imaging in recruitment: maintenance and methodological issues in Alzheimer's trials.
Suhy J
J Nutr Health Aging; 2012 Apr; 16(4):349-51. PubMed ID: 22499456
[TBL] [Abstract][Full Text] [Related]
19. Why would caregivers not want to treat their relative's Alzheimer's disease?
Karlawish JH; Casarett DJ; James BD; Tenhave T; Clark CM; Asch DA
J Am Geriatr Soc; 2003 Oct; 51(10):1391-7. PubMed ID: 14511158
[TBL] [Abstract][Full Text] [Related]
20. Vitamin E for Alzheimer's disease and mild cognitive impairment.
Isaac MG; Quinn R; Tabet N
Cochrane Database Syst Rev; 2008 Jul; (3):CD002854. PubMed ID: 18646084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
